Evaluation of the relevance of the growth modulation index (GMI) from the FFCD 0307 randomized phase III trial comparing the sequence of two chemotherapeutic regimens

Autor: du Rusquec, P., Guimbaud, R., Le Malicot, K., Gornet, J.-M., Nguyen, S., Lecomte, T., Khemissa-Akouz, F., Perrier, H., Bouché, O., Paoletti, X., Le Tourneau, C.
Zdroj: In ESMO Open August 2023 8(4)
Databáze: ScienceDirect